U.S. flag

An official website of the United States government

NM_000512.5(GALNS):c.1429_1455del (p.Glu477_Gln485del) AND Mucopolysaccharidosis, MPS-IV-A

Germline classification:
Uncertain significance (2 submissions)
Last evaluated:
Feb 1, 2021
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001261588.4

Allele description [Variation Report for NM_000512.5(GALNS):c.1429_1455del (p.Glu477_Gln485del)]

NM_000512.5(GALNS):c.1429_1455del (p.Glu477_Gln485del)

Genes:
LOC126862447:CDK7 strongly-dependent group 2 enhancer GRCh37_chr16:88884193-88885392 [Gene]
GALNS:galactosamine (N-acetyl)-6-sulfatase [Gene - OMIM - HGNC]
Variant type:
Deletion
Cytogenetic location:
16q24.3
Genomic location:
Preferred name:
NM_000512.5(GALNS):c.1429_1455del (p.Glu477_Gln485del)
HGVS:
  • NC_000016.10:g.88818038_88818064del
  • NG_008667.1:g.43907_43933del
  • NM_000512.5:c.1429_1455delMANE SELECT
  • NM_001323543.2:c.874_900del
  • NM_001323544.2:c.1447_1473del
  • NP_000503.1:p.Glu477_Gln485del
  • NP_001310472.1:p.Glu292_Gln300del
  • NP_001310473.1:p.Glu483_Gln491del
  • NC_000016.9:g.88884446_88884472del
Links:
dbSNP: rs1909818289
NCBI 1000 Genomes Browser:
rs1909818289
Molecular consequence:
  • NM_000512.5:c.1429_1455del - inframe_deletion - [Sequence Ontology: SO:0001822]
  • NM_001323543.2:c.874_900del - inframe_deletion - [Sequence Ontology: SO:0001822]
  • NM_001323544.2:c.1447_1473del - inframe_deletion - [Sequence Ontology: SO:0001822]

Condition(s)

Name:
Mucopolysaccharidosis, MPS-IV-A (MPS4A)
Synonyms:
MPS IVA; Morquio syndrome A; MPS 4A; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0009659; MedGen: C0086651; Orphanet: 309297; Orphanet: 582; OMIM: 253000

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001438857Pathology and Clinical Laboratory Medicine, King Fahad Medical City
no assertion criteria provided

(ACMG Guidelines, 2015)
Pathogenicgermlineclinical testing

Citation Link,

SCV001547966Laboratory of Diagnosis and Therapy of Lysosomal Disorders, University of Padova
criteria provided, single submitter

(ACMG Guidelines, 2015)
Uncertain significance
(Feb 1, 2021)
germlinecuration

PubMed (3)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedcuration
Arabgermlineyesnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Molecular testing of 163 patients with Morquio A (Mucopolysaccharidosis IVA) identifies 39 novel GALNS mutations.

Morrone A, Tylee KL, Al-Sayed M, Brusius-Facchin AC, Caciotti A, Church HJ, Coll MJ, Davidson K, Fietz MJ, Gort L, Hegde M, Kubaski F, Lacerda L, Laranjeira F, Leistner-Segal S, Mooney S, Pajares S, Pollard L, Ribeiro I, Wang RY, Miller N.

Mol Genet Metab. 2014 Jun;112(2):160-70. doi: 10.1016/j.ymgme.2014.03.004. Epub 2014 Mar 20. Erratum in: Mol Genet Metab. 2014 Nov;113(3):237.

PubMed [citation]
PMID:
24726177
PMCID:
PMC4203673

Molecular basis of mucopolysaccharidosis IVA (Morquio A syndrome): A review and classification of GALNS gene variants and reporting of 68 novel variants.

Zanetti A, D'Avanzo F, AlSayed M, Brusius-Facchin AC, Chien YH, Giugliani R, Izzo E, Kasper DC, Lin HY, Lin SP, Pollard L, Singh A, Tonin R, Wood T, Morrone A, Tomanin R.

Hum Mutat. 2021 Nov;42(11):1384-1398. doi: 10.1002/humu.24270. Epub 2021 Aug 23. Review.

PubMed [citation]
PMID:
34387910
PMCID:
PMC9291100
See all PubMed Citations (3)

Details of each submission

From Pathology and Clinical Laboratory Medicine, King Fahad Medical City, SCV001438857.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1Arabnot providednot providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From Laboratory of Diagnosis and Therapy of Lysosomal Disorders, University of Padova, SCV001547966.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedcuration PubMed (3)

Description

Absent from gnomAD v2.1.1 (PM2_moderate); protein length changes as a result of in-frame deletions/insertions in a nonrepeat region or stop-loss variants (PM4_moderate)

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Mar 26, 2023